Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
GfV 2024
Programm
Poster
Personen
Suche
DE
Alle Personen
Dr. Sarah Schmidt
Vienna / AT
Hookipa Pharma
Sortiert nach Typ
Datum
Discussant
27.03.2024
12:35
–
13:15
0 Min.
40 Min.
Discussion
Round table discussion “Do's and Don'ts for Applications”
Vortrag
25.03.2024
Poster
P 409
Next generation sequencing with Oxford Nanopore to monitor virus quasispecies in recombinant arenavirus vectors for immunotherapies
Clinical and diagnostic virology
25.03.2024
18:45
–
19:00
12 Min.
3 Min.
Abstract talk
O 023
An Arenavirus-Based SIV vaccine is immunogenic and efficacious in non-human primates
Vaccines
Weitere Beteiligungen
25.03.2024
Poster
P 409
Next generation sequencing with Oxford Nanopore to monitor virus quasispecies in recombinant arenavirus vectors for immunotherapies
Clinical and diagnostic virology
25.03.2024
Poster
P 146
The potential of arenavirus vector therapy for treatment of cancer and chronic infectious diseases
Vaccines
25.03.2024
18:45
–
19:00
12 Min.
3 Min.
Abstract talk
O 023
An Arenavirus-Based SIV vaccine is immunogenic and efficacious in non-human primates
Vaccines
v1.19.0
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz